Company intelligence
AOA Dx
Transforming Women’s Health with Breakthrough Cancer Diagnostics and AI
Biotechnology Research
Denver, US
56 employees
Founded 2020
1 public signals
About AOA Dx
AOA Dx is leading a revolutionary breakthrough in early-stage cancer detection, leveraging the transformative potential of AI and our proprietary biomarker technology. At the heart of this innovation is our GlycoLocate platform, a multi-omics approach powered by lipids, metabolites and proteins. This platform is setting a new gold standard in the quest for life-saving early cancer diagnostics. We are now advancing AKRIVIS GD™, a cutting-edge liquid biopsy test designed specifically for the early detection of ovarian cancer.
Verified activity
Signals from AOA Dx
1 published signal